Antibodies to FeRn and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9260520
APP PUB NO 20140248287A1
SERIAL NO

14168839

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOGEN HEMOPHILIA INC.;DYAX CORP.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bitonti, Alan J Annapolis, US 63 1684
Dumont, Jennifer Groton, US 13 95
Ladner, Robert Charles Ijamsville, US 82 1580
Liu, Liming Upper Dublin, US 55 176
McDonnell, Kevin Waltham, US 51 870
McGivney, James Hagerstown, US 6 46
Muruganandam, Arumugam Bangalore, IN 27 342
Sato, Aaron K Richmond, US 45 718
TenHoor, Christopher Hopkinton, US 23 150
Viswanathan, Malini Burlington, US 37 269
Wood, Clive Boston, US 31 1149

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 16, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00